How do you approach the development of an LGL clone in a NHL patient actively getting therapy?
Answer from: Medical Oncologist at Academic Institution
Most likely, i would monitor the clone and continue with the ongoing treatment plan. This is assuming the size of the clone was relatively small and that the patient was asymptomic in this regard. The development of a T-cell or NK-cell clone isnt necessarily indicative of a separate disease, does no...